"10.1371_journal.pone.0141266","plos one","2015-10-20T00:00:00Z","Hiroo Nakashima; Kentaro Oniki; Miki Nishimura; Naoki Ogusu; Masatsugu Shimomasuda; Tatsumasa Ono; Kazuki Matsuda; Norio Yasui-Furukori; Kazuko Nakagawa; Takateru Ishitsu; Junji Saruwatari","Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Hirosaki, Japan; Center for Clinical Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; Kumamoto Saishunso National Hospital, Koshi, Japan; Kumamoto Ezuko Ryoiku Iryo Center, Kumamoto, Japan","Conceived and designed the experiments: HN KN NO MS NYF TI JS. Performed the experiments: HN MN NO MS TO KM. Analyzed the data: HN KO MN NO MS TO KM JS. Contributed reagents/materials/analysis tools: HN MN NO MS KN TI JS. Wrote the paper: HN KO MN KN NYF TI JS.","Norio Yasui-Furukori has received grant/research support or honoraria from, and been on the speakers of Asteras, Dainippon, Eli Lilly, GSK, Janssen-Pharma, Meiji. Mochida, MSD, Otsuka, Pfizer, Takada and Yoshitomi. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The remaining authors declare that they have no competing interests.","2015","10","Hiroo Nakashima","HN",11,FALSE,7,6,8,7,TRUE,TRUE,FALSE,0,NA,FALSE
